Chenguang Biotech Group Co.,Ltd.’s Net Profit Rose 30.9% in First Quarter of 2023

Chenguang Biotech Group Co.,Ltd. (晨光生物科技集团股份有限公司) (300138.SZ) reported a net profit of 139.9 million yuan in the first quarter of 2023, up 30.9% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, up 14.7% year-on-year.

At the end of the reporting period, it had 7.6 billion yuan in total assets and 4.3 billion yuan in total liabilities, with a liability-to-asset ratio of 56%.